Skip to main content

Table 3 Cost breakdown of the total out-of-pocket patient payments (n=367)

From: Costs associated with febrile neutropenia in solid tumor and lymphoma patients – an observational study in Singapore

 

All of the febrile neutropenia episodes

Median cost (interquartile range), 2012 US$

Mean cost (95% CI), 2012 US$

Percentage breakdown

Ward

230 (145–504)

432 (375–488)

18.4%

Laboratory

171 (120–260)

314 (266–362)

13.3%

Radiology

17 (8–64)

88 (66–110)

3.7%

Prescription

507 (319–891)

829 (720–937)

35.2%

Other/Unknown

383 (226–661)

692 (585–800)

29.4%

Total

1,405 (901–2,442)

2,230 (1,976-2,483)

100%